ACTA and Access to Medicines
The Greens, European Free Alliance, 2011
42 Pages Posted: 9 Jan 2012
Date Written: October 6, 2011
Abstract
The Greens/EFA Internet Core Group in the European Parliament, and a collection of its individual members, commissioned this analysis of potential impacts of the Anti-Counterfeiting Trade Agreement (ACTA) on access to medicines in developing countries.” On the whole, ACTA negotiators created an agreement that shifts international “hard law” rules and “soft law” encouragements toward making enforcement of intellectual property rights in courts, at borders, by the government and by private parties easier, less costly, and more “deterrent” in the level of penalties. In doing so, it increases the risks and consequences of wrongful searches, seizures, lawsuits and other enforcement actions for those relying on intellectual property limitations and exceptions to access markets, including the suppliers of legitimate generic medicines. This, in turn, is likely to make affordable medicines more scarce and dear in many countries.
Keywords: Intellectual property, ACTA, generic medicines
Suggested Citation: Suggested Citation
Do you have a job opening that you would like to promote on SSRN?
